Skip to main content
$40.54 -$1.09 (-2.6%)

04:00 PM EST on 03/08/21

Editas Medicine (NASDAQ:EDIT)

CAPS Rating: 5 out of 5

Current Price $40.54 Mkt Cap $2.8B
Open $42.39 P/E Ratio 0.00
Prev. Close $40.54 Div. (Yield) $0.00 (0.0%)
Daily Range $40.07 - $45.10 Volume 2,888,514
52-Wk Range $14.01 - $99.95 Avg. Daily Vol. 3,000,836

Caps

How do you think NASDAQ:EDIT will perform against the market?

Add Stock to CAPS Watchlist

All Players

335 Outperform
6 Underperform
 

All-Star Players

169 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:EDIT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Midnight42 (78.99)
Submitted December 10, 2020

On verge of a genomic revolution, company will be collecting royalties for a long long time. (3/3)

LastPlaceLenny (61.12)
Submitted March 15, 2019

Not ready to take off yet, will out perform in long run, but not sure when that long run starts. Not this year.

NASDAQ:EDIT VS S&P 500 (SPY)

NASDAQ:EDIT Summary

Fools bullish on NASDAQ:EDIT are also bullish on:

Fools bearish on NASDAQ:EDIT are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EDIT.

Recs

0
Member Avatar 1russianguy (95.32) Submitted: 2/23/2021 1:00:51 PM : Outperform Start Price: $53.80 NASDAQ:EDIT Score: -22.70

best of us investors, best growth potential for next 3 years

Recs

0
Member Avatar TMFjimhalley (52.49) Submitted: 2/11/2021 11:48:06 AM : Outperform Start Price: $59.41 NASDAQ:EDIT Score: -29.45

The potential for the company's therapies is so huge, that it makes sense to stay for the ride. The company has no debt and $500 million in cash, so if it has a breakthrough with its CRISPR technology, it could pay off quite well.

Recs

0
Member Avatar Kman89 (44.84) Submitted: 1/31/2021 7:24:30 PM : Outperform Start Price: $61.64 NASDAQ:EDIT Score: -36.37

CRISPR is a great new technology and the company has a long runway of growth ahead.

Leaderboard

Find the members with the highest scoring picks in EDIT.

Score Leader

Dobby62

Dobby62 (44.43) Score: +242.71

The Score Leader is the player with the highest score across all their picks in EDIT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
freemarketmike < 20 6/7/2017 Outperform 5Y $15.43 +162.68% +56.74% +105.95 1 Comment
portefeuille 98.67 2/10/2016 Outperform 5Y $13.26 +205.73% +104.71% +101.02 0 Comment
FunesDMemorious 29.04 10/26/2016 Outperform 5Y $14.55 +178.63% +79.03% +99.59 0 Comment
CMFMLove 80.27 6/13/2017 Outperform 5Y $16.00 +153.38% +56.46% +96.92 1 Comment
portefeuille2 99.33 9/22/2016 Outperform 5Y $14.87 +172.63% +75.93% +96.70 0 Comment
SeriousK 29.51 3/9/2016 Underperform 5Y $42.70 -5.06% +91.47% +96.53 0 Comment
Playa14 < 20 6/9/2017 Outperform 5Y $16.08 +152.11% +56.38% +95.73 0 Comment
birdup 24.55 3/16/2020 Outperform 5Y $16.39 +147.42% +58.40% +89.02 0 Comment
forcel0 94.03 11/23/2016 Outperform 5Y $15.60 +159.87% +73.47% +86.40 0 Comment
Vavoom11 99.95 3/13/2020 Outperform 5Y $17.89 +126.61% +48.74% +77.86 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for EDIT.